» Articles » PMID: 10431157

CD26, Let It Cut or Cut It Down

Overview
Journal Immunol Today
Date 1999 Aug 4
PMID 10431157
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

The costimulatory properties of CD26 have been studied extensively and significant progress has been made in unravelling the complex nature of this molecule. Here, we summarize recent findings on molecular and functional characteristics of CD26. We argue that a multidisciplinary approach might reveal the molecular events underlying the role of CD26 in HIV infection and immune, inflammatory and endocrine responses.

Citing Articles

Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy.

Kotrulev M, Gomez-Tourino I, Cordero O Cancers (Basel). 2024; 16(13).

PMID: 39001488 PMC: 11240764. DOI: 10.3390/cancers16132427.


Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Aljohani H, Alrubaish F, Alghamdi W, Al-Harbi F Ther Innov Regul Sci. 2024; 58(4):622-633.

PMID: 38634983 DOI: 10.1007/s43441-024-00637-2.


Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors.

Rahim K, Shan M, Ul Haq I, Nawaz M, Maryam S, Alturki M J Inflamm Res. 2024; 17:1897-1917.

PMID: 38544813 PMC: 10968008. DOI: 10.2147/JIR.S442106.


A Systems Biology Approach Unveils a Critical Role of DPP4 in Upper Gastrointestinal Cancer Patient Outcomes.

Kotnala S, Dhasmana A, Dhasmana S, Haque S, Yallapu M, Tripathi M J Environ Pathol Toxicol Oncol. 2024; 43(2):43-55.

PMID: 38505912 PMC: 11419273. DOI: 10.1615/JEnvironPatholToxicolOncol.2023048056.


Incretin Therapy and Insulin Signaling: Therapeutic Targets for Diabetes And Associated Dementia.

Joshi D Curr Diabetes Rev. 2024; 21(4):57-63.

PMID: 38425117 DOI: 10.2174/0115733998279875240216093902.